Exemplos de uso de Nebulised em Inglês e suas traduções para o Português
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Inhalation of nebulised solutions may induce a cough reflex.
Bronchospasm(an acute reductionof≥ 15% in FEV1) is a complication associated with nebulised therapies.
Inhalation of nebulised tobramycin solutions may induce a cough reflex.
Bronchospasm can occur with inhalation of medicinal products andhas been reported with the use of nebulised tobramycin.
Inhalation of nebulised tobramycin produces high sputum concentrations and low plasma levels.
An acute reduction of≥ 15% in FEV1 is a complication associated with nebulised therapies, including Cayston see section 4.4.
To assess the effects of nebulised hypertonic(≥ 3%) saline solution in infants with acute viral bronchiolitis.
Sputum of cystic fibrosis patients exhibits an inhibitory action on the local biological activity of nebulised aminoglycosides.
Nebulised hypertonic saline solution may reduce these pathological changes and decrease airway obstruction.
Sore throat ormouth has been reported with nebulised colistimethate sodium and may occur with Colobreathe.
Nebulised hypertonic saline may be a beneficial treatment to manage acute bronchiolitis because it can improve airway hygiene.
There were no significant adverse effects noted with the use of nebulised hypertonic saline when administered along with bronchodilators.
Inhalation of nebulised solutions may induce a cough reflex which could aggravate underlying conditions see section 4.4.
Urea and creatinine levels should be reassessed after every 6 complete cycles of Vantobra therapy 180 days of nebulised aminoglycoside therapy.
Lignocaine pre-treatment, either intravenous or nebulised has been used to attenuate ocular and systemic responses to laryngoscopy and tracheal intubation.
This review was conducted to assess the effects of hypertonic(≥ 3%)saline solution administered via a nebuliser in infants with acute bronchiolitis, compared with nebulised normal(0.9%) saline.
No significant short-term effects(at 30 to 120 minutes)of one to three doses of nebulised hypertonic saline were observed among emergency department patients.
Patients treated with nebulised 3% saline had a significantly shorter mean length of hospital stay compared to those treated with nebulised 0.9% saline MD -1.15 days, 95% confidence interval(CI) -1.49 to -0.82, P< 0.00001.
All subjects were also required to have successfully completed a minimum of two cycles of nebulised tobramycin solution run-in prior to randomisation.
Given the clinically relevant benefit and good safety profile, nebulised hypertonic saline used in conjunction with bronchodilators should be considered an effective and safe treatment for infants with mild to moderate acute viral bronchiolitis.
Four emergency department-based trials did not show any significant short-termeffects(30 to 120 minutes) of up to three doses of nebulised 3% saline in improving clinical score and oxygen saturation.
Current evidence suggests nebulised 3% saline may significantly reduce the length of hospital stay among infants hospitalised with non-severe acute viral bronchiolitis and improve the clinical severity score in both outpatient and inpatient populations.